SLE is a chronic autoimmune disease involving multiple systems. Patients with SLE are
highly susceptible to infections due to the combined effects of their immunosuppressive …

The urgent need for lupus biomarkers was demonstrated in September 2011 during a
Workshop sponsored by the Food and Drug Administration: Potential Biomarkers Predictive …

Infection is a common problem and has become one of the leading causes of morbidity and
mortality in patients with systemic lupus erythematosus (SLE). The reasons for the high …

Immune checkpoint inhibitors (ICIs) are promising agents for treating melanoma. Given that
autoimmune skin diseases exhibit hyper immune reaction, investigation of immune cells …

System lupus erythematosus (SLE) is an immune‐complex‐mediated autoimmune condition
with protean immunological and clinical manifestation. While SLE has classically been …

Systemic lupus erythematosus (SLE) flares elicit progressive organ damage, leading to
disability and early mortality. This study evaluated clinical and immunologic factors …

Patients with the autoimmune disease multiple sclerosis (MS) typically present with the
clinically isolated syndromes (CIS) transverse myelitis (TM) or optic neuritis (ON). B-cell …

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease affecting multiple
organ systems. In the past 40 years, prognosis for patients with SLE has improved …

Introduction: Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with
heterogeneous manifestations. Of particular importance for clinicians are the precise …

Objectives Distinguishing flares from bacterial infections in systemic lupus erythematosus
(SLE) patients remains a challenge. This study aimed to build a model, using multiple blood …